Sadra Medical, which is developing a procedure to replace the aortic valve (for the less medically-savvy, that’s part of your heart), has raised $30 million in a third round of funding. The Campbell, Calif., company dubs its procedure “percutaneous aortic valve replacement,” and it involves placing the prosthetic valve in a patient’s heart by threading a catheter through their arteries. The round was led by Accuitive Medical Ventures, with participation from previous investors Boston Scientific, Finister, Firstmark Capital, Oakwood, ONSET Ventures, and SV Lifescience.

Sadra has now raised a total of $58 million, according to numbers from VentureWire.

VentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative enterprise technology and transact. Discover our Briefings.